| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |